Indoco Remedies (NSE:INDOCO) Research & Development: ₹795 Mil (TTM As of Mar. 2026)


NSE:INDOCO Indoco Remedies Ltd NSE:INDOCO
66 GF Score
Price ₹234.06
GF Value ₹358.97
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indoco Remedies Research & Development?

Indoco Remedies NSE:INDOCO +1.06% 66 Research & Development is ₹795 Mil as of Mar. 2026. GuruFocus rates NSE:INDOCO with a GF Score™ of 66/100 and a GF Value™ of ₹358.97 (Possible Value Trap). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Indoco Remedies's Research & Development for the three months ended in Mar. 2026 was ₹178 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹795 Mil.

Indoco Remedies  (NSE:INDOCO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Indoco Remedies Research & Development Related Terms

Indoco Remedies Research & Development Historical Data

* Premium members only.

The historical data trend for Indoco Remedies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indoco Remedies Research & Development Chart

Indoco Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 746.42 809.70 971.57 760.10 795.40

Indoco Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 173.90 216.60 218.10 183.10 177.60
NSE:INDOCO
66GF Score
Indoco Remedies Ltd NSE:INDOCO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indoco Remedies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹795 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹795 Mil mean?
Indoco Remedies (NSE:INDOCO) has a Research & Development of ₹795 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Indoco Remedies and its competitors.
Is Indoco Remedies' Research & Development too high?
Indoco Remedies' current Research & Development is ₹795 Mil. Overall, Indoco Remedies has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indoco Remedies' Research & Development compare to ZTS and UTHR?
Indoco Remedies' Research & Development of ₹795 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Indoco Remedies and its competitors. Indoco Remedies's current Research & Development is ₹795 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indoco Remedies stock overvalued right now?
Based on GuruFocus' analysis, Indoco Remedies (NSE:INDOCO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹358.97, compared to a current price of ₹234.06 — trading 34.8% below its estimated fair value. The current Research & Development is ₹795 Mil. Indoco Remedies' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Indoco Remedies (NSE:INDOCO), the current Research & Development is ₹795 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indoco Remedies (NSE:INDOCO) Overvalued in 2026?

Based on GuruFocus' analysis, Indoco Remedies stock appears to be undervalued. The current stock price of ₹234.06 is trading 34.8% below its estimated GF Value™ of ₹358.97. GuruFocus considers Indoco Remedies to be Possible Value Trap.

Key valuation signals for NSE:INDOCO:

  • Research & Development: ₹795 Mil
  • GF Value™: ₹358.97 vs. price of ₹234.06 (34.8% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the NSE:INDOCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indoco Remedies Business Description

Other Exchanges 532612:India
Address 166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.
66GF Score

Get the complete analysis for NSE:INDOCO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹234.06
Price
₹358.97
GF Value